Background Monocyte/macrophages are known to infiltrate the brain of patients with HIV-1 encephalitis (HIVE). In Alzheimer's disease brain, the origin of activated microglia has not been determined.
Introduction
Previous studies of the immunopathogenesis of Alzheimer's disease (AD) have described the role of local, brain-specific mechanisms of innate immunity. However, the role of a possible systemic inflammatory response has not been documented [1] . In AD brain, evidence for locally induced inflammation includes: the presence of activated complement components [2] [3] [4] ; alteration of cytokine levels, in particular of tumour necrosis factor-α [5] , interleukin-1 beta [6] , interleukin-6 [7] and transforming growth factor-β [8] ; and the presence of chemokines [9] , the cyclooxygenase 2 (COX-2) isoform [10 -12] , and acute phase reactants, such as α −1 antichymotrypsin [13] .
The AD process is initiated by extracellular amyloid-β deposits in limbic and association cortices [14] , which may activate astrocytes [15] and microglia [16] [17] [18] [19] . Whereas microglia are considered to be responsible for amyloid-β deposition, astrocytes may be neuroprotective [20] , and amyloid-β may lower the secretion of the neuroprotective amyloid precursor protein [21] . Yet few, if any studies, have considered the presence of blood-borne macrophages or T cells in the brain, suggesting that systemic immune responses do not contribute to AD pathogenesis, but rather that inflammation is attributed to brain microglia, which represent the innate immune system in the brain and thereby postulate activation by local factors, such as amyloid-β, phosphorylated τ, and mutated presenilin 1 and 2, create an 'autotoxic loop' of neurotoxicity [22, 23] .
Experimental studies, however, suggest that monocytes/ macrophages might be recruited into the brain and be neuronotoxic or neuroprotective. We demonstrated that monocytes are able to transmigrate across an in-vitro bloodbrain barrier (BBB) model when attracted by chemokines produced by amyloid-β-stimulated macrophages [24] . Monocyte/macrophages could damage neurons, as they do in HIV-1 encephalitis (HIVE) [25] [26] [27] , by the production of injurious cytokines [28, 29] , prostanoid products of COX-2 and COX-2 enzymes, and other toxic factors such as NO, glutamate and reactive oxygen species. On the other hand, microglia and macrophages could play a neuroprotective role [30] either by aiding the removal of amyloid deposits [31] , especially when activated by antibodies against amyloid-β [32] , or by secreting neurotrophic factors [33] . The neurotoxic and neuroprotective effects of macrophages might be similar in AD and HIVE [34] . Although the disruption of BBB by macrophages has been documented in HIVE [35] , BBB damage in AD has not been previously documented by neuropathological studies.
These considerations prompted us to use an 'antigen retrieval technique' for treatment of brain tissues to increase the immunocytochemical detection of leukocytes in the brain. Using this technique, we have noted a striking infiltration of HIVE and AD brains by COX-2-positive CD68 macrophages and, to a lesser degree, CD3 and B cells. The infiltration of the AD brain by macrophages and lymphocytes suggests that, in addition to the previously recognized local immune reaction, the AD brain is a target of a systemic immune response.
Materials and methods

Brain tissues
The HIVE study was performed with brain tissues of a 43-year-old male patient with HIVE (post-mortem interval 4 h), a 37-year-old male with HIVE (post-mortem interval 3 h) and two HIV-1-positive patients without HIVE: a 39-year-old HIV-1 positive male (post-mortem interval 3 h) without neuropathological abnormalities and a 46-year-old male with nonspecific white matter changes (post-mortem interval 7·5 h). The brain tissues were obtained from the Manhattan HIV Brain Bank and the Texas Repository for AIDS Neuropathogenesis Research. HIV-1 encephalitisn was diagnosed by a neuropathological examination performed by S. Morgello (a neuropathologist at Columbia who provided the HIV brain materials and reviewed the neuropathology). This was corroborated by a positive HIV-1 blood test and significant impairment on neuropsychological examination, classified as possible HIV-associated dementia.
The AD study component was performed with the brain tissues (temporal lobe and hippocampus) of eight demented patients (aged 68, 71, 73, 78, 79, 82, 84, 86 years) obtained from the UCLA ADRC Brain Bank. Seven patients had AD with varying degrees of amyloid angiopathy and one had vascular dementia without a significant AD pathological change. Senile plaques and neurofibrillary tangles were present in the frontal lobe and hippocampal tissues of the AD cases. The post-mortem interval was 5 -6 h. The normal controls were post-mortem temporal lobe, frontal lobe and hippocampal tissues from five patients (age 61, 62, 68, 83 and 99 years) without neuropathological findings, provided by the same Brain Bank.
Nonepileptogenic lateral temporal cortex obtained during epilepsy-related surgery was provided by M. Weinand, University of Arizona.
Immunocytochemistry
Paraffin embedded 6-µ tissue sections were baked at 60 °C for 30 min or overnight. Slides were deparaffinized in xylene, rehydrated, and treated with 3% H 2 O 2 . The sections requiring antigen retrieval were heated for 25 min in 0·01 M citrate buffer, pH 6, at 95-100 °C using 'Steamer Plus' (Black and Decker), as described by Shi et al. [36] . The sections were blocked for 10 min with 1:20 dilution of normal goat serum in Tris-buffered saline, and were stained using the LSAB 2 kit or the DAKO EnVision Doublestain System (DAKO, Carpinteria, CA); primary antibodies used are shown in Table 1 . The slides were examined using Olympus BX60 and the images were acquired using Olympus DP11 digital camera.
Confocal microscopy of amyloid-β β β β and CD68 cells
In the study of amyloid-β plaques, frozen sections of brain from AD patients were air-dried and fixed with 4% paraformaldehyde/ PBS for 30 min at room temperature. They were then washed three times with PBS, twice for 30 min with 0·2% Triton X-100/ PBS, and again three times with PBS. The sections were then treated with 70% formic acid / distilled water for 20 min at room temperature, rinsed with distilled water, and washed with PBS. The sections were incubated first in blocking serum (10% normal goat serum / 0·2% Triton X-100/ PBS) and then in a mixture of primary antibodies [(mouse monoclonal anti-CD68 (1:500) and rabbit polyclonal antiamyloid-β (1:200)] in 1% normal goat serum /0·2% Triton X-100/PBS. After washing once with 0·2% Triton X-100/ PBS and twice with PBS, a mixture of labelled secondary antibodies was added for 1 h at room temperature (goat antimouse IgG Alexa 488, Molecular Probes (1:100) and goat antirabbit IgG Texas Red (1:100)/ 1% normal goat serum/PBS/0·2% Triton X-100). The slides were mounted with ProLong Antifade Kit (Molecular Probes). The preparations were analyzed using a Leica TCS SP laser scanning confocal microscope (Heidelberg, Germany). Argon (488-nm line) and krypton (568-nm line) lasers excited Alexa 488 and Texas Red, respectively. Laser light was delivered to the tissue sections by a 488/568 primary dichroic beam splitter. On the 488-nm excitation pass, the Alexa 488 signal was collected with a spectral filter with a range of 500 -550 nm. The TR signal was collected with a spectral filter set to a range of 580-700 nm, with the 568 nm excitation pass. Scanning was done sequentially for each frame to eliminate any cross talk or bleed through from the two signals. Maximal projections and overlay maximal projections of the image series (approximately 30 for each image) were generated using Leica Confocal Software (Leica, Mannheim, Germany).
Data analysis
To evaluate the density of macrophage infiltration around microvessels, the slides were stained with anti-CD68 and examined using 10× and 40× objectives of the Olympus BX60 microscope to locate the vessel with the densest infiltration. To analyse the infiltration areas with CD68-positive macrophages or COX-2-positive cells in AD patients (n = 8) and control patients (n = 8), three 100× fields were selected in each case as follows: the first was taken at the area of highest density found with a low power objective, and the subsequent fields above and below the first field. The positively stained areas were measured using the Image-Pro Plus Version 4·1 program (Media Cybernetics, Silver Spring, MD), which enhanced immunostaining (colour filters) and automatically measured the area of each colour, as described previously [37] . The CD68-or COX-2-positive areas were analyzed by  [38] , using age as the covariate (age was not found to be significant) [ Table 2 ].
To measure perivascular leakage of serum proteins, the sections were stained with antibody to fibrinogen, and the area of the leakage and the cross-sectional area of each affected microvessel were measured using Scion software (NIH, Bethesda, MD; see Fig. 1g ,h) in 50 vessels (40× objective) starting at the most affected vessel and proceeding to the surrounding vessels. The total area of leakage was calculated as the sum of individual areas of leakage x i , where x i = area of leakage around a leaky vessel -cross-sectional area of the vessel (µm 2 ) [ Table 3 ]. The data were analyzed using the Kruskal-Wallis and Mann-Whitney tests. Mean CD68 area in three 1000-x fields of AD cases (n = 8) and control cases (n = 8) measured by the Image-Pro program.  with repeated measures showed P = 0·03 for the observed differences between AD (group mean = 110·5) and control cases (group mean = 68·0). ‡ Mean COX-2 areas in three 1000-x fields of AD cases (n = 8) and control cases (n = 8) measured by the Image-Pro program.  with repeated measures showed P = 0·004 for the observed differences between AD (group mean = 143·5) and control cases (group mean = 11·6).
Results
COX-2-positive macrophages infiltrate AD and HIVE brains
Initially, routine immunocytochemistry of frozen and paraffin embedded sections revealed only a few CD68 cells and no T or B cells. We then compared the results of brain tissues from patients with AD and HIVE with or without pretreatment by the antigen retrieval technique. This technique dramatically increased the detection of CD68 cells in both AD (cf. Fig. 1a,b) and HIVE (cf. Fig. 1c,d) . In both disorders, more infiltrating cells were noted in perivascular spaces than in brain parenchyma. Macrophage infiltration was generally greater in the HIVE cases than in the AD cases (cf. Fig. 1b-d) . Only two perivascular macrophages were noted around a microvessel in the frontal lobe of an HIV-1-positive patient without neuropathological findings (Fig. 1e) , and only one perivascular macrophage was observed in a microvessel in the temporal lobe of a 43-year-old patient with epilepsy (Fig. 1f ) , and in the frontal lobe of an 83-year-old patient without neuropathological findings (not shown).
As shown previously, a large subset of perivascular macrophages in the AD brain was COX-2-positive as well as inducible NO synthase (iNOS)-positive [39] . Statistical analysis of the CD68-positive and COX-2-positive areas showed significantly greater areas of macrophage infiltration (P = 0·03) and COX-2 expression (P = 0·004) in the AD than in the control brains [ Table 2 ].
Infiltrating CD68+ macrophages in AD and HIVE tissues
In HIVE, brain infiltration with monocyte-derived macrophages has previously been shown to result from transendothelial migration of monocytes facilitated by immune alterations of the BBB induced by HIV-1 [40] , bacterial lipopolysaccharide [25] or cocaine [40] . Accordingly, in HIVE CD68 cells were found predominantly in perivascular spaces (Fig. 2d) ; some were positive for lysozyme (data not shown) and appeared distinct from ramified microglia.
In the AD brain, a majority of infiltrating CD68+ cells also appear to originate from blood monocytes rather than from brain microglia, as suggested by their position in the vessel wall (Fig. 3b) , predominantly perivascular distribution (Fig. 1b) , large size, and absence of ramified morphology (Fig. 2a-c) . Furthermore, T and B cells and neutrophils also infiltrated the AD brain, supporting the idea of leukocyte migration across the BBB. In the temporal lobe of an AD patient, large oval CD68 macrophages were found predominantly in perivascular areas (Fig. 2a) , but also in and around amyloid-β plaques (Fig. 2b) . In addition to being encircled by large macrophages, the amyloid-β containing plaques were surrounded by LN3-positive ramified microglia, described by other investigators as enclosing senile plaques [19,41; Fig. 2c , note two characteristic ramified microglia (→) and a large macrophage-like cell (arrowhead)]. Both the large CD68 macrophages and the ramified microglia stained positively with anti-CD68 and anti-LN3 antibodies.
Tight junction protein ZO-1 is disrupted in AD and HIVE brains
Blood-brain barrier was identified by immunostaining of the tight junction protein ZO-1, which revealed linear staining surrounding the endothelial cell nuclei in brain vessels of a normal control brain (not shown). In the temporal lobe of a patient with AD, mononuclear (Fig. 3a) CD68-positive cells (Fig. 3b) were noted at the sites of ZO-1interruptions. Similarly, in the frontal lobe of a HIVE patient, abundant CD68 cells were noted in the vessel wall (Fig. 3d) . In this HIVE brain, ZO-1 was completely absent from the vessel wall, as demonstrated by immunostaining of an adjacent section (Fig. 3c) . Contrasting with this disruption in HIVE and AD, the ZO-1 pattern was not disrupted in the brain vessels of a control case, although perivascular macrophages were present (not shown).
Brain microvessels in AD, HIVE and HIV-1-positive brains leak fibrinogen
Perivascular leakage of fibrinogen was noted around brain microvessels in all these disorders. The leakage involved fewer vessels and smaller leaks (e.g. one of four vessels; Fig. 4a ) in AD compared with HIVE (e.g. three of four ). The control group had significantly smaller area of fibrinogen leakage compared to AD and HIVE groups. The Kruskall-Wallis analysis of variance on the three groups, P = 0·0116. The Mann-Whitney test: HIV vs. AD, P = 0·034; AD vs. control, P = 0·0339; HIVE vs. control, P = 0·0210. vessels; Fig. 4b ). To analyse these differences, we examined 50 vessels in each brain and measured the areas of perivascular leakage around individual leaky vessels. The greatest area of leakage was observed among the HIVE and HIV-1 cases who also had significant drug abuse (multidrug or alcohol; Table 3 ]. Alzheimer's disease vessels showed less leakage than HIVE vessels, but both AD and HIV cases had significantly greater leakage did the than controls (P = 0·016). A single patient with vascular dementia ( VD) had a smaller area of leakage than the AD cases.
T and B lymphocytes also infiltrate AD and HIVE brains
In addition to macrophages, CD3 T cells also infiltrated AD (Fig. 5a) and HIVE (Fig. 5b) brain tissues in a perivascular fashion. Compared with the frequently dense infiltration of T cells, only rare B cells were present around the vessels in the AD and HIVE brains (data not shown). In addition, occasional myeloperoxidase-positive polymorphonuclear leukocytes were present in perivascular spaces in both conditions (data not shown).
Amyloid-β β β β-containing macrophages infiltrate amyloid-β β β β plaques and vessels with amyloid angiopathy
The export of amyloid-β from the brain is considered to play a crucial role in AD pathogenesis [42] . Microglia phagocytize amyloid-β [41] using receptor for advanced glycation end products (RAGE) [43, 44] and class A and B scavenger receptors [45] . We investigated the uptake of amyloid-β by macrophages infiltrating plaques and the vessel walls using confocal microscopy. Within an amyloid-β plaque (Fig. 6a) , CD68 macrophages (Fig. 6b) containing intracellular amyloid-β (Fig. 6c) were surrounded by lacunae devoid of amyloid-β (empty spaces in Fig. 6a,c) . In the amyloid angiopathy afflicted brain, rows of amyloid-β-containing macrophages (reminiscent of the 'rosettes' described by Wegiel et al. [20] ) encircled the thick vessel wall infiltrated by amyloid-β; however, no lacunae were visible around these macrophages (Fig. 6d-f ).
Discussion
In this immunocytochemical study, we observed robust infiltration of HIVE and AD brains by COX-2-and CD68-positive macrophages and, to a lesser degree, by CD3 and CD20 lymphocytes. These inflammatory cells may have a crucial significance for the pathogenesis and treatment of AD, as COX-2-inhibiting nonsteroidal anti-inflammatory drugs reduce the risk of AD [46] . Although several groups have reported increased expression in the AD brain of the COX-1 and /or COX-2 enzymes of the prostaglandin pathway without precise localization [11, 13, 47] , the upregulation of COX-2-infiltrating macrophages has been reported by us only very recently [48] .
In AD, a majority of CD68 macrophages infiltrate perivascular spaces, but some macrophages invade amyloid-β plaques or encircle congophilic vessels. Monocyte migration across BBB is generally accepted in HIVE [49] but, up to now, has not been documented in AD. In rodents, BBB migration of blood-derived mononuclear cells and transformation into microglia-like cells is well documented [39, 50] . Thus the CD68-positive cells within brain parenchyma could represent monocyte/macrophages rather than ameboid microglia [51] . In AD brain tissues, the infiltrating CD68 cells have predominantly perivascular locations, but some are seen in the vessel wall and some are lysozyme positive. Frequent T cells and rare B cells also infiltrate AD brain tissues. Taken together, these data suggest that the COX-2-positive macrophages in AD and HIVE might have a hematogenous origin.
The position of some CD68 cells in the microvessel wall at the site of interruption of ZO-1 in the AD brain suggests that these cells could disrupt interendothelial tight junctions and damage BBB. Monocyte migration produces BBB damage in HIVE. Rhodes noted leakage of serum albumin into the neuropil in the brains of HIVE patients [52] . Petito and coworkers noted T lymphocyte and monocyte infiltration of the choroid plexus with disruption of the blood/ cerebrospinal fluid (CSF) barrier in AIDS patients [53] . Power and coworkers [54] observed diffuse myelin pallor in the subcortical white matter, which they attributed to the damage of BBB but not to demyelination. Recently, widespread disruption of occludin and ZO-1 proteins in endothelial tight junctions in HIVE has been attributed to monocyte migration across BBB [35, 55] . Tight junction damage in AD is more discrete compared with tight junction damage in HIVE, as shown by less ZO-1 disruption and fibrinogen leakage [6, 7] . These neuropathological findings are in agreement with previous biochemical studies of the cerebrospinal fluid, which suggested only weak and inconstant evidence of a leak across the blood-CSF barrier in AD [56] [57] [58] [59] [60] [61] [62] . In a morphometric study of BBB in brain biopsies from patients with AD, it was shown that brain microvascular endothelia showed a number of abnormalities suggesting 'leakiness' [63] . In HIV-positive subjects with neurological abnormalities, CSF showed robust findings with evidence of intrathecal IgG synthesis and albumin leakage [64] . The parallel between a greater monocyte/macrophage infiltration and a stronger fibrinogen leakage in HIVE compared with AD suggests that BBB disruption may be related to monocyte migration.
The robust infiltration of the brain by activated macrophages and lymphocytes in AD is suggestive of a systemic immune response executed by the cells belonging to innate and adaptive systems. In HIVE, macrophages and microglia are injurious to neurons, both directly through the induction of toxic products [65, 66] and indirectly by the disruption of the BBB during migration, which is fostered by HIV-1 infection [35, 49] . In AD, the role of these two populations of bone marrow-derived cells could represent a two-edged sword. As in HIVE, cytokines, prostanoids, NO and reactive oxygen species produced by macrophages and microglia may be toxic to neurons. On the other hand, macrophages could phagocytize [67] and export amyloid-β from the brain [68 -70] and thus decrease the amyloid burden within it.
Taken together, our study suggests that in both AD and HIVE brains, monocyte/macrophages migrate across BBB. The role of these phagocytic cells might involve phagocytosis of amyloid-β in amyloid plaques in AD brains similar to the phagocytosis of amyloid-β in vitro [26] . These cells also infiltrate the vessel wall in amyloid angiopathy, but without visible phagocytosis, except in the rare case of granulomatous angiitis with Congophilic amyloid angiopathy [71] . As in HIVE, AD monocyte migration through BBB appears to incur adverse effects. and P01AG12435) given to HVV.
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